Theravance Biopharma Inc

TBPHNASDAQ
$17.04
0.0140.08%
마지막 업데이트: Sep 23, 5:58 PM
인수합병: Theravance Biopharma (TBPH) was acquired by Zymeworks (ZYME) on Wednesday, September 23, 2026 for $929M paid in cash

Theravance Biopharma Market Sentiment

Market sentiment signals for Theravance Biopharma (TBPH): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Neutral
Short Interest▼ 5.2% short float
Options Flow— N/A
Insider Activity▼ Net Seller (30d)

Analyst Consensus

Neutral

7 analysts

Options Flow (P/C)

—

Avg Consensus PT

$15

-13.5%

Highest Price Target

$17

-0.3%

B. Riley Securities

Lowest Price Target

$10

-41.3%

Leerink Partners

Short Interest

5.2%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Sep 24, 2026BTIG
Julian Harrison—
——SuspendsNeutral
Jul 7, 2026HC Wainwright & Co.
Douglas Tsao—
-0.3%$15 → $17DowngradeBuy→Neutral